Neurotherapeutics Course
  • Home
  • About This Training Program
  • 2023 Course Schedule
  • 2023 Course Materials
  • Faculty
  • UC Davis Map
  • Important Information
  • Course Evaluation
  • Student Instructions
  • 2021 Course Lecture Videos
Thank You Students and Faculty
We thank the students and faculty for participating in the 2023 offering of Training in Neurotherapeutics Discovery for Academic Scientists.
Picture
The Robert and Margrit Mondavi Center for the Performing Arts

​2024 Course Offering

The 2023 offering of Training in Neurotherapeutics Discovery and Development for Academic Scientists was held Tuesday, March 14 to Friday, March 17, 2023 at the University of California, Davis in Davis, California, in facilities within the University Gateway District. Lectures will be held in Vanderhoef Studio Theatre of the Robert and Margit Mondavi Center for the Performing Arts. The application period for the 2024 course offering will begin this summer. Please check back for application information.

Supported by National Institute of Neurological Disorders and Stroke Grants 1R25NS077582, 1R25NS099170 and 1R25NS129110.

Picture
Students and faculty of the 2022 offering of Training in Neurotherapeutics Discovery and Development.

From the 2022 Course Offering

Picture
Picture
Picture

From Previous Course Offerings​

Picture
Students and faculty of the 2020 offering of Training in Neurotherapeutics Discovery and Development.

From the 2020 offering of Training in Neurotherapeutics Discovery and Development.

From the 2019 offering of Training in Neurotherapeutics Discovery and Development.


Picture
Students and Faculty of the 2019 offering of Training in Neurotherapeutics Discovery and Development.

Picture
Picture
From the 2018 offering of Training in Neurotherapeutics Discovery and Development.
Picture
Students and Faculty of the 2018 offering of Training in Neurotherapeutics Discovery and Development.

Picture

Picture
From the 2016 offering of Training in Neurotherapeutics Discovery and Development.

Supported by National Institute of Neurological Disorders and Stroke Grant R25NS099170.
Collaborator’s Logos